Justice Official: Understand What Ammunition Sunshine Might Provide Enforcement, Consider Voluntary Disclosures

Drugmakers fretting about how to properly report payments to physicians under the final Sunshine Act rule should take a step back and look at what the reported payments may tell enforcement agencies, such as the federal and state Justice Departments, government officials say. While the HHS Office of Inspector General is charged with enforcing the Sunshine Act, the underlying information may reveal concerns of interest to the Justice Department, such as anti-kickback issues or false claims issues, U.S. Attorney Marilyn May said Tuesday at The National Disclosure Summit in Washington, D.C. Drugmakers should pretend the Justice Department is in the room with them and think about its perspective, she said.
Drug Industry Daily